Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 2/20 | 0.66 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | RHEB | Q15382 | 1/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.54 |
| ▸ | HTR3B | O95264 | 1/20 | 0.54 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 1/20 | 0.54 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.54 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29527229 | 1.00 | PIN1 (0.66) | PIN1HRH4HRH3HSD17B10RAB9A | |
| SCHEMBL3498398 | 0.87 | CHEK2 (0.60) | PIN1HRH4HRH3HSD17B10RAB9A | |
| SCHEMBL523253 | 0.86 | RHEB (0.54) | PIN1HRH4HRH3RAB9APOLB | |
| SCHEMBL11229268 | 0.86 | HRH4 (0.58) | PIN1HRH4HRH3HSD17B10RAB9A | |
| SCHEMBL7152026 | 0.85 | HTR3E (0.57) | HRH4HRH3HSD17B10RAB9AALDH1A1 | |
| SCHEMBL4806542 | 0.81 | PIN1 (0.68) | PIN1POLBRHEBTDP1EGLN1 | |
| SCHEMBL13343598 | 0.80 | KDM4E (0.57) | PIN1HRH4HSD17B10POLBALDH1A1 | |
| SCHEMBL2243706 | 0.79 | PIN1 (0.66) | PIN1HRH4HRH3HSD17B10ALDH1A1 | |
| SCHEMBL21063893 | 0.79 | PIN1 (0.66) | PIN1HRH4RHEBTDP1EGLN1 | |
| SCHEMBL28429593 | 0.79 | PIN1 (0.66) | PIN1HRH4HRH3RHEBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12469929-B2 | Separator, electrical apparatus containing such separator, and preparation method thereof | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-11-11 | — | — | US | claimed |
| EP-4397399-A2 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2024-07-10 | — | — | EP | claimed |
| CN-108350034-B | Antimicrobial polymyxin derived compounds | 莫纳什大学 | 2022-03-11 | — | — | CN | claimed |
| EP-3774001-A1 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2021-02-17 | — | — | EP | claimed |
| US-20210016232-A1 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | EVOVE LTD (GB) | 2021-01-21 | — | — | US | claimed |
| WO-2012175823-A1 | NOVEL HYBRID ORGANIC/INORGANIC IM-22 SOLID, AND USE THEREOF IN THE SEPARATION OF MULTI-BRANCHED PARAFFINS FROM LINEAR AND SINGLE-BRANCHED PARAFFINS | IFP Energies Nouvelles (FR) | 2012-12-27 | — | — | WO | claimed |
| EP-2167077-A2 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-03-31 | — | — | EP | claimed |
| US-20090023741-A1 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AG (DE) | 2009-01-22 | — | — | US | claimed |
| WO-2008152099-A2 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-18 | — | — | WO | claimed |
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4660193-A1 | INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF | Korea Research Institute of Chemical Technology (KR) | 2025-12-10 | — | — | EP | disclosed |
| US-12234398-B2 | Metal organic framework (MOF) glass composite comprising metal halide perovskite | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-02-25 | — | — | US | disclosed |
| US-20240376377-A1 | A METAL ORGANIC FRAMEWORK (MOF) GLASS COMPOSITE COMPRISING METAL HALIDE PEROVSKITE | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-11-14 | — | — | US | disclosed |
| WO-2024162746-A1 | INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF | 한국화학연구원 | 2024-08-08 | — | — | WO | disclosed |
| EP-1405852-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-07 | — | — | EP | disclosed |
| EP-1051176-A4 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARM PROD INC (US) | 2002-06-12 | — | — | EP | disclosed |
| CN-1291892-A | Substituted oxoazaheterocyclyl factor Xa inhibitors | AWENTIS PHARMACEUTICAL INC (US) | 2001-04-18 | — | — | CN | disclosed |
| EP-1051176-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | Aventis Pharmaceuticals Products Inc. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-2000032590-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-1999037304-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023741-A1 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR | PTGER2, PTGER1, PTGDR2 | PIN1 2950/4885HRH4 129/4885HRH3 203/4885 |
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | PIN1 3096/4885HRH4 3815/4885HRH3 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.